ArticleInternational journal of general medicine2025
Clinical Effects of Traditional Chinese Medicine + Azithromycin in the Treatment of Mycoplasma Pneumonia.
Article in International journal of general medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Clinical Efficacy of Qingke Mixture in Treating Mycoplasma Pneumonia in Children: A Randomized Controlled Trial.International journal of general medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To explore the clinical effect of Traditional Chinese Medicine (TCM) plus azithromycin in the treatment of Mycoplasma pneumonia (MP). Methods: This was a retrospective study including the clinical data of 119 patients with MP treated at Taihe County Hospital of Traditional Chinese Medicine from April 2021 to November 2023. According to treatment records, 58 cases were treated with conventional therapy and azithromycin (azithromycin group), and 61 cases were treated with conventional therapy, azithromycin, and Xiaoxianxiong decoction and Weijing decoction and acupoint application (TCM + azithromycin group). The treatment outcomes, levels of inflammatory status indicators before and after treatment, respiratory function status, and incidence of adverse reactions were analyzed between the two groups. Results: The overall effective rate of TCM + azithromycin group was significantly higher than that of azithromycin group ( Conclusion: Compared with treatment with azithromycin alone, intervention with TCM + azithromycin can significantly improve the respiratory function of patients with MP, reduce the degree of inflammatory response, and enhance the overall treatment effect without increasing the incidence of adverse reactions. Core Tip: This study indicates that intervention with traditional Chinese medicine and azithromycin can significantly improve the respiratory function of MP patients, reduce the degree of inflammatory response, improve overall treatment efficacy, and is safe.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.